But why there are resident macrophages in the plaque in the first place, and what do they do in the atherosclerotic lesion? The resident macrophages are multifaceted and possibly alter their forms and functions during the different stages of atherosclerosis. Typically macrophages are motile phagocytic cells and eat up nonself substances such as modified LDL through macropinocytosis or scavenger receptor-mediated pathways, resulting in the formation of the foam cells-a heavily lipid loaded, inactive, dormant macrophage -that are the manifestation of the atherosclerotic plaque. These lipid laden foam cells activates and secretes numerous receptors and pro-inflammatory markers (IL-1, IL-6, TNF, CCL2, CCL5 and CXCR4) makes the lesion more vulnerable [1] . It also secretes macrophage retention factors such as netrin 1 and semaphorin 3E, which further block their escape route [2] . The magnitude of lipid and cholesterol loading, activation of receptors, and metabolic state of the cells, make them misguided and immotile.
Nevertheless these resident macrophages become misguided and trapped in the lesion. The consequences to this "cluelessness" are tremendous. In the accompanying article, Dr. Kathryn Moore and colleagues [2] describe elegantly experimental evidence that helps us understand why macrophages become clueless to get out from the lesion. Molecules such as netrin-1 appear to be key players in this phenomenon.
It helps to review first briefly netrin-1 and its role in resident macrophages ( Figure 1 ). Netrins are secreted proteins and structurally resembles the extracellular matrix protein laminin. Firstly, it has been discovered as guidance cues for cell and axonal migration in the central nervous system [3] . It mediates axonal chemoattractant activity via binding to the deleted in colorectal cancer (DCC) and neogenin receptors, and repulsion via the uncoordinated-5 (UNC5) receptors [3, 4] . Over the years it has been established that netrins can play a vital role in multiple organs and tissues, including the vasculature, heart, lung, pancreas, muscle and mammary gland, by mediating cell migration, cell-cell interactions and cell-extracellular matrix adhesion. Of note, the role of netrin-1 in atherosclerosis and retention of macrophages in the plaque is highly debatable.
Accumulating data have established the signal cues for netrin-1 and its receptors outside the nervous system, for example in atherosclerosis [2] , organogenesis [5] , angiogenesis [6] and tumorigenesis [7] , proposing that netrin-1 modulates cell migration in a broader context. It has also been found to be upregulated in many diseases [8] [9] [10] , and can easily be measured in blood plasma. Thus it would be good biomarkers for the risk and severity assessment of the disease.
Controversy exists regarding the identity of endothelial receptors mediating these effects in the vasculature. Several others have reported that the inhibition of netrin-1 canonical receptors, DCC, neogenin, and the Unc5b [5, 10] did not abrogate netrin signaling [11] and additional findings have reinforced the idea that a one-to-one relationship between ligand and receptor is too simplistic.
Why macrophages become clueless to get out from the lesion? The mechanism by which lipid-laden macrophage gets trapped is poorly understood. It could be speculate that some proteins or signal may obstruct with macrophage migratory signals which may prolong the stay of macrophages in the lesion. However, of late, van gill and colleagues published remarkable findings why these misguided macrophages trapped in atherosclerotic lesion in Nature Immunology. They found that signal blocker protein called netrin1, known for the central nervous system. Authors have suggested that netrin 1 was also secreted by resident macrophages activated by oxLDL in the plaque of atherosclerotic mice, where it inactivates the migration of lipid laden resident macrophages in response to chemical cues (CCR7) linked to their egress from plaques, hence these cells accumulated within the plaque. However, in another experiment in netrin-1 knockout mice they observed reduced atherosclerotic symptoms and resulted in fewer plaque-resident macrophages [2] . Findings of the research suggested that netrin-1 proteins are involved in multiple physiological responses, ranging from angiogenesis to inflammation, making it an attractive potential therapeutic target. On the other hand, studies evaluating the potential clinical benefits of up-and down-regulation of netrin-1 have yielded seemingly contradictory results [2, 12] . With the increasing understanding of the role of netrin1, oxLDL and resident macrophages, new research areas and treatment strategies are beginning to emerge. Based on these data, future research in this area could benefit in identifying potential diagnostic biomarkers and novel therapies for coronary heart disease.
